A look at clinical trial design for new antimicrobials for the adult population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A look at clinical trial design for new antimicrobials for the adult population

Published:2019-10-23 Issue:11 Volume:12 Page:1037-1046
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Bassetti Matteo¹²,Giacobbe Daniele Roberto¹²,Peghin Maddalena³,Irani Paurus⁴

Affiliation:

1. Clinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy

2. Department of Health Sciences, University of Genoa, Genoa, Italy

3. Infectious Diseases Division, Department of Medicine University of Udine, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy

4. Global Medical Affairs, Pfizer INC, New York, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2019.1680283

Reference66 articles.

1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

2. Critical Importance of a One Health Approach to Antimicrobial Resistance

3. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

4. Antibiotic resistance is ancient

5. Antimicrobial resistance – moving forward?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the single-channel characteristics of OprD (OccAB1) porins from hospital strains of Acinetobacter baumannii;European Biophysics Journal;2023-04

2. Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective;Expert Review of Anti-infective Therapy;2022-04-25

3. Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications;Current Opinion in Infectious Diseases;2021-01-05

4. Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance;Antibiotics;2020-09-22

5. Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective;Expert Opinion on Pharmacotherapy;2020-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3